Sintilimab plus eribulin and carboplatin in patients with metastatic triple-negative breast cancer (SECURE): a phase II, multicenter trial. (PubMed, J Immunother Cancer) - Oct 25, 2026 - No abstract available
Journal • P2 data • Breast Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer
|
|
Daining Wang; Haifeng Li; Huadi Shi; Lijia Zhou; Lixia Li; Lulu Zhang; Meiting Chen; Mengqian Ni; Peng Sun; Qingru Zhou; Qiufang Zheng; Shu Dun; Shusen Wang; Xin An; Yanhong Su; Yanxia Shi; Yongkui Lu
|